Stockscreener 앱 받기
5.1884
0.38%
-0.0116
전일 마감가:
$5.20
열려 있는:
$5.25
하루 거래량:
178.82K
Relative Volume:
0.15
시가총액:
$663.62M
수익:
$193.01M
순이익/손실:
$-12.15M
주가수익비율:
-57.65
EPS:
-0.09
순현금흐름:
$454.00K
1주 성능:
-2.45%
1개월 성능:
+1.57%
6개월 성능:
+40.38%
1년 성능:
-9.60%
1일 변동 폭
$5.16
$5.2525
1주일 범위
$5.135
$5.70
52주 변동 폭
$2.37
$6.18
Cytek Biosciences Inc Stock (CTKB) Company Profile
명칭
Cytek Biosciences Inc
전화
(877) 922-9835
주소
47215 LAKEVIEW BOULEVARD, FREMONT
CTKB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
5.19 | 664.90M | 193.01M | -12.15M | 454.00K | -0.09 |
|
ABT
Abbott Laboratories
|
107.25 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.24 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
355.73 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.27 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.68 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 재개 | Morgan Stanley | Equal-Weight |
| 2025-05-09 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-01-31 | 다운그레이드 | Goldman | Buy → Sell |
| 2023-12-14 | 개시 | Stephens | Overweight |
| 2023-07-19 | 개시 | Raymond James | Mkt Perform |
| 2022-01-06 | 재개 | Piper Sandler | Overweight |
모두보기
Cytek Biosciences Inc 주식(CTKB)의 최신 뉴스
Aug Closing: Is Cytek Biosciences Inc stock overvalued or fairly priced2025 Major Catalysts & Technical Buy Zone Confirmations - baoquankhu1.vn
Institutional owners may take dramatic actions as Cytek Biosciences, Inc.'s (NASDAQ:CTKB) recent 6.9% drop adds to one-year losses - simplywall.st
Why Cytek Biosciences Inc. (8EQ) stock attracts HNW investorsJuly 2025 Big Picture & High Conviction Investment Ideas - bollywoodhelpline.com
CYTEK BIOSCIENCES Q4 2025 Earnings Preview: Recent $CTKB Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
Cytek Biosciences (NASDAQ:CTKB) Shares Up 8.2%Here's What Happened - MarketBeat
Cytek Biosciences, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year 2025 - marketscreener.com
Cytek Biosciences, Inc. (NASDAQ:CTKB) Receives Average Rating of “Hold” from Analysts - Defense World
Cytek Biosciences Preliminary Q4 Revenue Up 8% - Nasdaq
Cytek Biosciences Reports Preliminary Revenue of Approximately $201 Million for Full Year 2025 - Quiver Quantitative
Cytek Biosciences Announces Preliminary Fourth Quarter and Full Year 2025 Revenue Results - GlobeNewswire
Cytek Biosciences, Inc. (NASDAQ:CTKB) Receives Average Rating of "Hold" from Analysts - MarketBeat
Will Cytek Biosciences Inc. (8EQ) stock top growth indexesWeekly Profit Report & High Accuracy Trade Signal Alerts - ulpravda.ru
Why Cytek Biosciences Inc. stock is a must watch in 20252025 Pullback Review & Community Consensus Trade Signals - Улправда
Is Cytek Biosciences Inc. stock attractive for retirement portfoliosRisk Management & Technical Confirmation Trade Alerts - Улправда
What analyst consensus implies for Cytek Biosciences Inc. (8EQ) stockBond Market & Weekly High Return Forecasts - Улправда
CTKB FinancialsIncome Statement - Quiver Quantitative
Cytek Biosciences (NASDAQ:CTKB) Given New $5.00 Price Target at TD Cowen - MarketBeat
User | bentoncourier.comCytek Biosciences, Inc.Common Stock (Nasdaq:CTKB) Stock Quote - FinancialContent
Is Cytek Biosciences (NASDAQ:CTKB) Using Debt In A Risky Way? - Futubull
2026 world cup standings odds: How currency fluctuations impact Cytek Biosciences Inc. stock2026 world cup usa national team round of 16 playmakers transition play match prediction analysis - Улправда
Cytek Biosciences Inc 8EQ Stock Analysis and ForecastCandlestick Pattern Analysis & Affordable Portfolio Strategies - earlytimes.in
What risks investors should watch in Cytek Biosciences Inc stockGap Down & Free Safe Capital Growth Stock Tips - Bộ Nội Vụ
How currency fluctuations impact Cytek Biosciences Inc. stockStock Screening Results & Big Data Market Reports - bollywoodhelpline.com
What dividend safety score for Cytek Biosciences Inc. stockLong-Term Investment Plans & Fast Profit Trading Strategies - bollywoodhelpline.com
Cytek Biosciences webinar explores lung cell communication advances - Traders Union
Cytek Biosciences Data Breach Investigation - Claim Depot
Cytek Biosciences Data Breach Exposes Social Security Numbers - Claim Depot
Book value per share of Cytek Biosciences, Inc. – DUS:8EQ - TradingView — Track All Markets
How Cytek Biosciences Inc. stock responds to policy changes2025 Trading Volume Trends & Accurate Buy Signal Alerts - Улправда
Pharma News: How Cytek Biosciences Inc. stock responds to policy changesJuly 2025 Sector Moves & Expert-Curated Trade Recommendations - Улправда
Is Cytek Biosciences Inc. (8EQ) stock a buy on weakness2025 EndofYear Setup & Safe Capital Preservation Plans - DonanımHaber
Is Cytek Biosciences Inc. (8EQ) stock at risk of policy regulationTrade Ideas & High Accuracy Trade Signal Alerts - DonanımHaber
Cytek Biosciences Earnings Notes - Trefis
Cytek Biosciences, Inc. (NASDAQ:CTKB) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Cytek BioSciences Inc (CTKB) expanding its growth trajectory ahead - Setenews
Why Cytek Biosciences Inc. (8EQ) stock stays on buy listsQuarterly Portfolio Report & High Accuracy Buy Signal Tips - Newser
Institutional Owners May Consider Drastic Measures as Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Recent US$58m Drop Adds to Long-term Losses - 富途牛牛
Brown Capital Management LLC Has $24.17 Million Stock Position in Cytek Biosciences, Inc. $CTKB - MarketBeat
Is Cytek Biosciences Inc. stock overvalued by current metricsJuly 2025 EndofMonth & Precise Entry and Exit Recommendations - Newser
Can Cytek Biosciences Inc. stock beat market expectations this quarter - Newser
Can Cytek Biosciences Inc. (8EQ) stock sustain revenue momentumGDP Growth & Safe Capital Growth Plans - Newser
Why Cytek Biosciences Inc. stock attracts global investorsWeekly Trend Report & Fast Gain Stock Tips - Newser
Can Cytek Biosciences Inc. stock maintain operating marginsEarnings Growth Summary & Entry Point Strategy Guides - Newser
Is Cytek Biosciences Inc. (8EQ) stock attractive for dividend growthJuly 2025 Sentiment & Community Verified Trade Alerts - Newser
Cytek Biosciences Inc (CTKB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Cytek Biosciences Inc 주식 (CTKB) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| McCombe William D. | Chief Financial Officer |
Jun 02 '25 |
Buy |
2.78 |
35,000 |
97,300 |
55,746 |
2.90%
0.36%
자본화:
|
볼륨(24시간):